Rezolute, Inc. — Director's Dealing 2013

Feb 9, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2013-01-31

Reporting Person: Mantripragada Sankaram (Chief Scientific Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6000000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$0.75	2018-01-30	Common Stock (1000000)		Direct

Footnotes

F1: Dr. Mantripragada owns 6,000,000 shares of common stock of the Issuer.

F2: Pursuant to the terms of the Reporting Person's option to purchase common stock ("Common Stock Option"), 50% of the Common Stock Option vested on January 30, 2013 with the remaining 50% of the Common Stock Option to vest monthly over the thirty-six months following January 30, 2013.